C22orf13 Antikörper (AA 51-150) (Biotin)
-
- Target Alle C22orf13 (GUCD1) Produkte
- C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))
-
Bindungsspezifität
- AA 51-150
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser C22orf13 Antikörper ist konjugiert mit Biotin
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human
- Homologie
- Mouse,Rat,Dog,Horse
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human C22orf13
- Isotyp
- IgG
-
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))
- Andere Bezeichnung
- C22orf13 (GUCD1 Produkte)
- Synonyme
- C22orf13 antikoerper, LLN4 antikoerper, 1110038D17Rik antikoerper, C17H22orf13 antikoerper, wu:fi27d12 antikoerper, zgc:152874 antikoerper, guanylyl cyclase domain containing 1 antikoerper, GUCD1 antikoerper, Gucd1 antikoerper, gucd1 antikoerper
- Hintergrund
-
Synonyms: C22orf13, CG13760 gene product [Drosophila melanogaster] homolog, Chromosome 22 open reading frame 13, CV013_HUMAN, LLN4, MGC1842, OTTHUMP00000198388, Protein LLN4, Uncharacterized protein C22orf13.
Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf13 gene product has been provisionally designated C22orf13 pending further characterization.
- Gen-ID
- 83606
-